Last updated: 22 June 2019 at 3:28am EST

Charles J Mcallister Net Worth




The estimated Net Worth of Charles J Mcallister is at least $1.69 millió dollars as of 9 May 2007. Charles Mcallister owns over 13,750 units of DaVita Inc stock worth over $1,693,736 and over the last 21 years Charles sold DVA stock worth over $0.

Charles Mcallister DVA stock SEC Form 4 insiders trading

Charles has made over 7 trades of the DaVita Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Charles exercised 13,750 units of DVA stock worth $331,650 on 9 May 2007.

The largest trade Charles's ever made was exercising 25,500 units of DaVita Inc stock on 26 May 2005 worth over $285,090. On average, Charles trades about 11,250 units every 137 days since 2003. As of 9 May 2007 Charles still owns at least 10,999 units of DaVita Inc stock.

You can see the complete history of Charles Mcallister stock trades at the bottom of the page.



What's Charles Mcallister's mailing address?

Charles's mailing address filed with the SEC is , , , , .

Insiders trading at DaVita Inc

Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler, és Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.



What does DaVita Inc do?

about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,



Complete history of Charles Mcallister stock trades at DaVita Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $331,650
9 May 2007
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $154,463
7 Aug 2006
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $205,190
17 Feb 2006
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $285,090
26 May 2005
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $62,500
15 Dec 2004
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $73,800
8 Mar 2004
Charles J Mcallister
Chief Medical Officer
Opció Gyakorlat $184,500
6 Aug 2003


DaVita Inc executives and stock owners

DaVita Inc executives and other stock owners filed with the SEC include: